Yutaka Yoshida is a Professor of Neuroscience at the Brain and Mind Research Institute, Weill Cornell Medical College. His research focuses on neural circuit development, semaphorin signaling, and mechanisms of motor recovery after spinal cord injury. Current Affiliation: Weill Cornell Medical College Institute: Brain and Mind Research Institute His work spans molecular neuroscience, pain research, and translational studies on corticospinal and sensory-motor circuits. Recent publications highlight his contributions to understanding semaphorin-plexin interactions in axonal guidance and neuropathic pain modulation. Scientific trends in his articles include: Neural Circuitry: Corticospinal motor control, vestibulospinal pathways Repair Mechanisms: Spinal injury recovery, microglial phagocytosis Signaling Pathways: Semaphorin-plexin, Bax/Bak-caspase He has extensive experience in proteomic analysis of kidney glomerulus and neural development, though no specific awards or student advisees are detailed in the provided text.
Genevieve Albouy serves as a Lecturer in the Department of Human Movement Sciences at KU Leuven and is an active member of the KU Leuven Brain Institute (LBI). Her academic profile centers on the intersection of motor control, memory systems, and sleep neuroscience, with particular emphasis on neurodegenerative conditions like Parkinson's disease. She contributes to interdisciplinary research through collaborative projects examining how sleep architecture influences motor memory consolidation. Dr. Albouy's research program investigates how sleep-dependent processes mediate motor memory consolidation, with special focus on phase-specific neural mechanisms during slow-wave sleep. Her work employs multimodal approaches including fMRI, EEG, and non-invasive brain stimulation to dissect cortico-striatal-hippocampal network interactions during motor learning. Current projects explore schema-mediated memory integration, targeted memory reactivation techniques, and the impact of Parkinson's disease on online/offline learning dynamics, revealing compensatory neural mechanisms in neurodegenerative populations. Analysis of her recent publication trajectory shows concentrated investigation into sleep-motor memory interactions, with increasing emphasis on clinical translation for Parkinson's disease rehabilitation. Her work demonstrates how targeted interventions during specific sleep phases can enhance motor memory consolidation, while her Parkinson's research identifies paradoxical offline learning enhancements that may inform novel neurorehabilitation strategies. Dr. Albouy has secured significant research funding as promoter of the project 'Modulating motor memory with noninvasive brain stimulation: a multimodal neuroimaging study' (2017-2023) and co-promoter of 'Schema and Motor Memory: A Multimodal Neuroscience Study' (2019-2024) and 'Connectivity in Large-Scale Brain Networks and Sleep-Dependent Motor Memory Consolidation' (2019-2023). She serves as co-supervisor for doctoral candidates, including Reverberi's thesis on schema and motor memory, and actively collaborates with international teams studying sleep-dependent memory processes. As a core member of the KU Leuven Brain Institute, she contributes to interdisciplinary neuroscience initiatives focusing on large-scale brain networks. Her laboratory work integrates sleep monitoring, neuroimaging, and behavioral paradigms to investigate memory consolidation mechanisms, with recent expansions into clinical applications for neurodegenerative disorders through collaborations with movement disorder specialists.
Elizabeth Johnson is an Adjunct Professor of Marketing at the The Wharton School , University of Pennsylvania, where she serves as Executive Director & Senior Fellow of the Wharton Neuroscience Initiative . Her research bridges vision science and business , focusing on visual behavior, eye tracking, and applications to consumer decision-making and marketing strategies . She previously spent 14 years at Duke University as a faculty member in Neurobiology and Associate Director of the Duke Institute for Brain Sciences. PhD in Neural Science, New York University AB in Psychobiology, Mount Holyoke College Johnson's research spans retinal physiology , early visual cortex processing, and social cognition in visual navigation. Her work includes collaborations with Lenovo to develop personalized color display technology and co-teaching a course on visual marketing with Professor Barbara Kahn. Recent publications highlight her expertise in eye tracking , neural mechanisms of vision , and translational neuroscience applications to business. She has contributed to in vivo cortical physiology methodologies, macaque V1 neurophysiology , and biomimetic design research. Her interdisciplinary approach extends to public health interventions for perinatal intimate partner violence.
Jimcy Platholi is an Assistant Professor of Neuroscience at Weill Cornell Medical College, affiliated with the Brain and Mind Research Institute. Their research focuses on neuroinflammation in neurodegenerative diseases, synaptic transmission mechanisms, and protein phosphatase regulation. Ph.D. (2008) and B.A. (1997) from Weill Cornell Graduate School of Medical Sciences M.A. (1999) from New York University Current research examines neuroinflammatory processes in perimenopausal Alzheimer's disease models , with a focus on hippocampal region-specific alterations. Earlier work investigated anesthetic effects on sodium channels (Na v 1.3) and synaptic spine dynamics. Recent publications demonstrate expertise in neurodegenerative mechanisms , with emphasis on Alzheimer's disease , cerebral amyloid angiopathy , and neuroinflammatory biomarkers . Earlier studies explored protein phosphatase regulation and neurogenetic pathways in auditory development and schizophrenia. Active as a Principal Investigator since 2019, they have secured multiple NIH grants for research on synaptic mechanisms of general anesthetics and neuroinflammatory processes in neurodegenerative diseases.
Tyler K. Perrachione is an Assistant Professor in the College of Health and Rehabilitation Sciences: Sargent College at Boston University. He directs the Communication Neuroscience Research Laboratory, focusing on developmental disorders of language and reading, neural plasticity in auditory processing, and speech perception mechanisms. Ph.D., Neuroscience – Massachusetts Institute of Technology M.A., Linguistics – Northwestern University B.A., Linguistics and Cognitive Science – Northwestern University Dr. Perrachione's research explores how atypical neural adaptation impacts conditions like dyslexia and autism spectrum disorder (ASD), with a focus on cortical systems for language, working memory, and voice recognition. His work also investigates speech motor learning and the role of noninvasive brain stimulation in enhancing language acquisition. Recent publications highlight trends in auditory neuroscience, including studies on white matter organization in ASD, dual-task interference in speech processing, and the limitations of musical training in enhancing auditory neural coding. His lab employs multimodal techniques such as fMRI, EEG, and pupillometry to examine speech perception and neural plasticity. NARSAD Young Investigator Award (2016) NIH R03 DC014045 Grant (2015–2018) Peter Paul Career Development Professorship (2013) Walle Nauta Awards for Teaching (2012, 2011) Angus McDonald Award (2010) NSF Graduate Research Fellowship (2008–2011) Dr. Perrachione teaches courses such as "Reading, Language, and the Brain" and "Applied Speech Science" at Boston University. His research has been presented at major conferences, including the Acoustical Society of America and Organization for Human Brain Mapping. The Communication Neuroscience Research Laboratory he leads bridges clinical and cognitive neuroscience to address speech and language disorders.
Dr. David Leopold is a Senior Investigator and Chief of the Section on Cognitive Neurophysiology and Imaging at the National Institute of Mental Health (NIMH) within NIH. He directs the Neurophysiology Imaging Facility, a joint core facility sponsored by NIMH, NINDS, and NEI. His research focuses on understanding the neural mechanisms underlying visual perception and consciousness. Key research areas include: Large-scale brain activity in visual perception Neural mechanisms of stimulus visibility Perceptual interpretation vs physical stimuli Social stimulus processing in primate brains Neural plasticity during visual learning His laboratory combines behavioral, neurophysiological, and fMRI measurements with pharmacological manipulations to study functional circuitry. Recent publications examine primate white matter architecture, neuronal plasticity, and face processing networks. Technical innovations include: Special microelectrodes for longitudinal neuron tracking Integration of diffusion-weighted MR imaging Multi-modal experimental designs
Dr. Thomas T. G. Hahn is a researcher at the Central Institute of Mental Health Mannheim (ZI), affiliated with the Department of Theoretical Neuroscience. His work focuses on cortico-hippocampal interactions and neural dynamics in vivo. Current faculty at Central Institute of Mental Health Mannheim Specializes in Theoretical Neuroscience Research interests include neural circuit dynamics , functional connectivity , and computational modeling of cortical-hippocampal systems, particularly examining spontaneous persistent activity and UP-DOWN state transitions in vivo. His publications since 2006 demonstrate expertise in applying advanced statistical models like hidden Markov analysis to neurophysiological data, with a focus on cortico-entorhinal and corticocortical network dynamics. Key methodologies: In vivo electrophysiology Core research areas: Neural network interactions, cortical plasticity
Kert Mätlik is a neuroscientist specializing in molecular mechanisms of neurodegenerative diseases and stroke pathology. Affiliated with Tallinn University of Technology, he holds a Doctor's Degree from the University of Helsinki (2017) and a Master's Degree from Tallinn University of Technology (2005). His research focuses on neurotrophic factors, particularly MANF and CDNF proteins, and their therapeutic potential in neurological disorders. Education: Doctor's Degree (2017), University of Helsinki, Institute of Biotechnology Master's Degree (2005), Tallinn University of Technology Dr. Mätlik's research program investigates cell-type-specific responses in neurodegenerative conditions, with significant contributions to understanding Huntington's disease mechanisms and stroke recovery processes. His work employs advanced molecular techniques to profile specific neuronal populations in human brain tissue, revealing critical insights into selective neuronal vulnerability. Recent publications demonstrate his leadership in developing methodologies for isolating and analyzing nuclei from specific neuronal types in human cerebral cortex and striatum. Analysis of his publication trends shows a consistent focus on translational neuroscience, bridging molecular mechanisms with potential therapeutic applications. His work spans neurodegenerative diseases, stroke pathology, and pain mechanisms, with increasing emphasis on human tissue studies in recent years. Scientific Recognition: 2002 First Prize in National Student Research Competition Artur Linnu Scholarship in Gene Technology Dr. Mätlik maintains active research collaborations across international institutions, contributing to our understanding of neurotrophic factor signaling and developing novel approaches for treating neurological disorders. His current work continues to advance the field of cell-type-specific analysis in neurodegenerative disease research.
Dr Daniel Roberts is a Senior Lecturer in the Department of Psychology within the Faculty of Health and Life Sciences at the University of Liverpool. His research focuses on the neurocognitive bases of visual and language processing, their interconnectedness, and how these processes become disrupted in conditions such as dyslexia, visual neglect, object agnosias, face recognition disorders, and semantic impairments. Dr Roberts completed his PhD in Cognitive Neuropsychology at the University of Manchester in 2010 under the supervision of Prof Matt Lambon-Ralph, following an MRes in Research Methods (2006) and BSc in Psychological Sciences (2005), also from the University of Manchester. PhD (2010): Cognitive Neuropsychology, University of Manchester MRes (2006): Research Methods, University of Manchester BSc (2005): Psychological Sciences, University of Manchester His research employs a multimethod approach including cross-population behavioral studies (individuals with brain damage, developmental disorders, and neurotypical individuals), neuroimaging, awake craniotomy, and visual psychophysics. Key areas of investigation include disorders of reading (developmental and acquired dyslexias), vision (e.g., neglect), object processing (agnosias), face recognition (prosopagnosia), semantics (e.g., dementias, HSVE), and bilingualism effects on visual and phonological processing in dyslexic readers. Dr Roberts' recent publications demonstrate a strong focus on dyslexia research, particularly examining visual and phonological processing impairments across different languages and orthographic depths. His work combines theoretical cognitive neuropsychology with practical clinical applications, aiming to develop better diagnostic tools and interventions. He has published in leading journals including Cognitive Neuropsychology, Annals of Dyslexia, Frontiers in Psychology, and Cerebral Cortex. As a supervisor, Dr Roberts works with several PhD students including Emma Austin (researching imagery in aphantasia), Rachel Dudley-Jones (studying substance use and neurocognitive processing in collaboration with Liverpool John Moores University), and Qi Zhou (investigating the role of language in arithmetic and algebraic operations in children). He serves as Module Coordinator for RESEARCH DISSERTATION IN PSYCHOLOGY (PSYC646) and RESEARCH METHODS AND STATISTICS (PSYC640), and teaches the RESEARCH PROJECT module (PSYC340). Emma Austin: Imagery in aphantasia (Co-supervisor: Dr Reshanne Reeder) Rachel Dudley-Jones: Substance use and neurocognitive processing (Co-supervisors: Dr Samantha Brooks, Prof Cathy Montgomery, Dr Kanayo Umeh, Prof Kate Cockcroft) Qi Zhou: Role of language in arithmetic and algebraic operation in children (Co-supervisors: Dr Jike Qin, Prof Jeong Jin Yu) Dr Roberts maintains active clinical collaborations through honorary research fellowships with The Walton Centre NHS Foundation Trust (since 2018), Central and North West London NHS Foundation Trust (since 2020), and The Hillingdon Hospitals NHS Foundation Trust (since 2020), focusing on stroke health informatics and improving neurosurgical interventions for brain tumor patients. He is a member of several professional organizations including the British Neuroscience Association, British Psychological Society, and Society for the Scientific Study of Reading.
Jørgen Rungby serves as a Clinical Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen. His clinical appointment is at Gentofte Hospital (Niels Steensens Vej 2-4, 2820 Gentofte), part of Region Hovedstaden, where he specializes in Internal Medicine with a focus on Endocrinology. His work bridges academic research and clinical practice in metabolic disorders. Professor Rungby's research spans multiple critical areas in metabolic health, with particular emphasis on diabetes pathophysiology, hormone signaling, and neurological complications of metabolic disorders. His work investigates the complex relationship between glucose metabolism, insulin resistance, and cognitive function, as well as the role of various hormones including glucagon, GIP, and FGF21 in metabolic regulation. His research demonstrates a strong translational focus, moving from basic molecular mechanisms to clinical applications and therapeutic development. Rungby's publication record shows consistent high-impact research output, with numerous publications in leading journals including Nature Metabolism, Diabetologia, and Diabetes Research and Clinical Practice. His work demonstrates expertise in both clinical trials methodology and basic science approaches, with recent studies examining time-restricted eating interventions, cardiovascular outcomes of diabetes medications, and molecular mechanisms of hormone receptors. His research often involves large collaborative efforts across multiple institutions. Professor Rungby actively supervises research projects and collaborates with numerous colleagues across the metabolic research field, contributing to significant advancements in understanding diabetes complications and novel therapeutic approaches. His work has garnered attention across multiple platforms, including news outlets, academic social media, and professional networks.
Rhonda Voskuhl, M.D., is a Professor in the Department of Neurology at the David Geffen School of Medicine, University of California, Los Angeles. She serves as Director of the UCLA Multiple Sclerosis Program and holds the Jack H. Skirball Chair in MS. With over 20 years of continuous research funding, her work bridges clinical observations and laboratory discoveries through a 'Bedside to Bench to Bedside' approach. Neurology Faculty UCLA MS Program Director Jack H. Skirball Chair Her research focuses on sex differences in multiple sclerosis , exploring hormonal therapies like estriol and testosterone for neuroprotection. She investigates X chromosome contributions to autoimmune susceptibility, astrocyte transcriptomics, and cholesterol homeostasis in remyelination. Recent publications highlight neuroprotective mechanisms, DNA methylation patterns, and cortical atrophy imaging. Neuroimmunology Neuroendocrinology Epigenetic Regulation Translational Clinical Trials Voskuhl mentors at postdoctoral, graduate, and undergraduate levels while maintaining active clinical practice in MS care. Her laboratory employs cutting-edge techniques including voxel-based morphometry and single-cell transcriptomics to advance MS treatment strategies.
Masaki Kakeyama is a Professor at the Faculty of Human Sciences , Waseda University, Japan. With a Ph.D. from Waseda University, he leads research at the intersection of behavioral neuroscience, environmental toxicology, and developmental neurobiology. Key Affiliations: Japan Society of Endocrine Disrupters Research, Japanese Society of Toxicology, Japan Neuroscience Society Research Focus spans neurodevelopmental impacts of environmental chemicals (dioxins, BPA, PCB congeners), neuronal migration mechanisms, and schema-based memory consolidation. His work explores how prenatal exposures alter medial prefrontal cortex and hippocampal function, leading to behavioral inflexibility and cognitive deficits in rodent models. Scientific Contributions include: Characterizing aryl hydrocarbon receptor (AhR) overactivation effects on cortical development Developing FlavorMap and IntelliCage automated behavioral assays Demonstrating neuronal heterotopia -induced distant brain region dysfunction Identifying developmental origins of metabolic disorders via maternal dioxin exposure Awards: Encouragement Award, Japanese Society for Hygiene (2012) Methodological Innovations include fluorescence laser microdissection-RTqPCR for single-cell gene expression analysis and live imaging techniques for neurochemical dynamics assessment. Education: Ph.D. in Life Sciences (1995) from Graduate School of Human Sciences, Waseda University.
Professor Toshio Ohshima is a leading researcher at Waseda University's School of Advanced Science and Engineering, specializing in Neuroscience and Neurochemistry . His work primarily investigates the molecular mechanisms of neurodegenerative diseases such as Alzheimer's and Parkinson's, focusing on collapsin response mediator proteins (CRMPs) and cyclin-dependent kinase 5 (Cdk5) pathways. His research has identified CRMP2 phosphorylation as a key therapeutic target for neuroprotection. Education: MD and PhD from Yamanashi Medical University His research spans diverse areas including axon guidance , dendritic growth , and neuroregenerative mechanisms . The articles reveal trends in targeting CRMP phosphorylation for therapeutic intervention across multiple diseases. Scientific Awards: Japan Society for Neurochemistry Encouragement Award (2001) His studies on Alzheimer's disease emphasize amyloid-β pathology, while Parkinson's research explores dopaminergic neuron protection. Collaborative efforts with Takashi Saito and Hiroki Sasaguri have advanced transgenic mouse models . Current work focuses on natural compounds and genetic therapies for neurodegenerative conditions.
Dr. Kaori Ishii is a Professor at the Faculty of Sport Sciences, School of Sport and Sciences at Waseda University in Japan. With a Doctor of Medicine from Tokyo Medical University (2009) and graduate studies at JF Oberlin University Graduate School of International Studies Human Sciences (2005), she has established herself as a leading researcher in sports sciences and public health. Dr. Ishii's educational background bridges medical science and human sciences, providing her with a unique interdisciplinary perspective. Her Doctor of Medicine from Tokyo Medical University in 2009 laid the foundation for her research in health outcomes, while her earlier graduate work at JF Oberlin University focused on international studies and human sciences, informing her approach to public health interventions. Her research primarily focuses on understanding the relationships between physical activity, sedentary behavior, and health outcomes across different age groups. Dr. Ishii has made significant contributions to the field of sedentary behavior research, particularly examining how screen time, sitting patterns, and physical activity affect children's academic performance, older adults' frailty, and various metabolic health markers. Her work often incorporates the influence of built environment factors on physical activity patterns, with studies conducted in dense urban Asian contexts. Analysis of Dr. Ishii's extensive publication record reveals several consistent research themes. She has pioneered research on the joint associations of physical activity and screen time with academic performance in children. More recently, her work has expanded to include innovative interventions such as virtual reality exergames to reduce cardiometabolic risk, and investigations into how dietary patterns affect biological aging. Her research frequently employs objective measurement tools like accelerometers and integrates multiple methodologies from epidemiology to experimental physiology. Dr. Ishii has received recognition for her work, including the 4th Japan Society of Health Education and Research Encouragement Award in 2014. Her research has been supported by numerous grants, particularly through WASEDA'S Health Study, a cohort study she has been involved with since its launch in 2014. As a principal investigator on the WASEDA'S Health Study, Dr. Ishii leads a multidisciplinary research team examining the relationships between physical activity, sedentary behavior, dietary patterns, and various health outcomes in Japanese adults. Her work often involves international collaborations, particularly with researchers from Australia, Canada, and the United States, reflecting the global relevance of her research on physical activity and health.
Eman Soliman is an Assistant Professor at the Brody School of Medicine , East Carolina University, specializing in Pharmacology & Toxicology . Her research focuses on neuroimmune interactions in traumatic brain injury recovery, with a particular emphasis on efferocytosis, microglial and macrophage function, and neuroinflammatory signaling pathways. B.S. in Pharmaceutical Sciences, Zagazig University, Egypt M.Sc. in Pharmacology, Zagazig University, Egypt Ph.D. in Pharmacology and Toxicology, East Carolina University Post-doctoral Fellowships in Immunology (East Carolina University) and Neuroimmunology (Virginia Tech) Her work employs transgenic mouse models, bone marrow chimeras, and advanced 3D imaging to investigate spatial, temporal, and sex-specific regulation of inflammation resolution in the brain. Key themes include the role of EphA4 signaling in efferocytosis, microglia-macrophage communication, and neuroprotective mechanisms after injury. Recent publications highlight her contributions to understanding endothelial-astrocyte interactions, Tie2/Akap12 signaling, and NLRX1-cGAS-STING pathways in neuroinflammation. Articles also explore ABCG1 deficiency, PPARγ roles in granulomatous inflammation, and translational applications of cannabinoids in cancer and neuroinflammatory diseases. The Soliman Lab collaborates with researchers on topics like EphA4 deletion, prostamide therapies, and mitochondrial dysfunction in chronic diseases. Current projects aim to identify targetable mechanisms for enhancing neuroprotection and functional recovery following brain injury.
